Zhiyu Xiao

Department of Hepatobiliary Surgery, Sun Yat-sen University

Research Area

Biography

Zhiyu Xiao has not added Biography.
If you are Zhiyu Xiao and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 1	2025

Other Publications

Article	Year
Silencing Fas-associated phosphatase 1 expression enhances efficiency of chemotherapy for colon carcinoma with oxaliplatin. World journal of gastroenterology\| PubMed ID: 20039457	2010
Duodenal pseudolymphoma: a case report and review of literature. World journal of gastroenterology\| PubMed ID: 21912478	2011
High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma. Human pathology\| PubMed ID: 22406368	2012
Comparison of duct-to-mucosa and end-to-side pancreaticojejunostomy reconstruction following pancreaticoduodenectomy. Hepato-gastroenterology\| PubMed ID: 22773303	2013
Is the end of the T-tube drainage era in laparoscopic choledochotomy for common bile duct stones is coming? A systematic review and meta-analysis. Annals of surgery\| PubMed ID: 23059495	2013
Long-term results of the paraesophagogastric devascularization with or without esophageal transection: which is more suitable for variceal bleeding? World journal of surgery\| PubMed ID: 24590450	2014
Restoration of miR-193b sensitizes Hepatitis B virus-associated hepatocellular carcinoma to sorafenib. Cancer letters\| PubMed ID: 25034398	2014
Hepatitis B Virus X Protein (HBx) Is Responsible for Resistance to Targeted Therapies in Hepatocellular Carcinoma: Ex Vivo Culture Evidence. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 26059188	2015
Patterns and prognostic value of lymph node dissection for resected perihilar cholangiocarcinoma. Journal of gastroenterology and hepatology\| PubMed ID: 26250532	2016
The impact of liver resection on survival outcomes of hepatocellular carcinoma patients with extrahepatic metastases: A propensity score matching study. Cancer medicine\| PubMed ID: 30117307	2018
Treatment strategy for huge hepatocellular carcinoma with intrahepatic metastasis and macrovascular invasion: a case report and literature review. Journal of cancer research and therapeutics\| PubMed ID: 30539879	2018
Uridine-cytidine kinase 2 promotes metastasis of hepatocellular carcinoma cells via the Stat3 pathway. Cancer management and research\| PubMed ID: 30568496	2018
ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma. Journal of experimental & clinical cancer research : CR\| PubMed ID: 30646949	2019
Development and external validation of prognostic nomograms in hepatocellular carcinoma patients: a population based study. Cancer management and research\| PubMed ID: 31118768	2019
A Novel lncRNA IHS Promotes Tumor Proliferation and Metastasis in HCC by Regulating the ERK- and AKT/GSK-3β-Signaling Pathways. Molecular therapy. Nucleic acids\| PubMed ID: 31128422	2019
Novel nomograms to predict lymph node metastasis and liver metastasis in patients with early colon carcinoma. Journal of translational medicine\| PubMed ID: 31182111	2019
Identification and validation of a prognostic four-genes signature for hepatocellular carcinoma: integrated ceRNA network analysis. Hepatology international\| PubMed ID: 31321712	2019
Integrated Nomograms for Preoperative Prediction of Microvascular Invasion and Lymph Node Metastasis Risk in Hepatocellular Carcinoma Patients. Annals of surgical oncology\| PubMed ID: 31773517	2020
Targeting adenosinergic pathway enhances the anti-tumor efficacy of sorafenib in hepatocellular carcinoma. Hepatology international\| PubMed ID: 31802389	2020
HBx/ERα complex-mediated LINC01352 downregulation promotes HBV-related hepatocellular carcinoma via the miR-135b-APC axis. Oncogene\| PubMed ID: 32157216	2020
Surgical Resection and Prognostic Analysis of 142 Cases of Hilar Cholangiocarcinoma. The Indian journal of surgery\| PubMed ID: 32288384	2018
Integrated nomogram based on five stage-related genes and TNM stage to predict 1-year recurrence in hepatocellular carcinoma. Cancer cell international\| PubMed ID: 32368186	2020
A Novel Staging System to Forecast the Cancer-Specific Survival of Patients With Resected Gallbladder Cancer. Frontiers in oncology\| PubMed ID: 32850391	2020
PRL-3 facilitates Hepatocellular Carcinoma progression by co-amplifying with and activating FAK. Theranostics\| PubMed ID: 32929353	2020
Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression. Oncogene\| PubMed ID: 33051595	2021
Molecular Targets of Ferroptosis in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma\| PubMed ID: 34466409	2021
Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma. Frontiers in molecular biosciences\| PubMed ID: 34977159	2021
INPP5F translocates into cytoplasm and interacts with ASPH to promote tumor growth in hepatocellular carcinoma. Journal of experimental & clinical cancer research : CR\| PubMed ID: 34996491	2022
Prognostic nomogram for predicting cancer-specific survival in patients with resected hilar cholangiocarcinoma: a large cohort study. Journal of gastrointestinal oncology\| PubMed ID: 35557567	2022
Circular RNA circSFMBT2 downregulation by HBx promotes hepatocellular carcinoma metastasis via the miR-665/TIMP3 axis. Molecular therapy. Nucleic acids\| PubMed ID: 36159591	2022
Analysis of the potential association between ferroptosis and immune in hepatocellular carcinoma and their relationship with prognosis. Frontiers in oncology\| PubMed ID: 36776357	2022
Retraction Note: HBx/ERα complex-mediated LINC01352 downregulation promotes HBV-related hepatocellular carcinoma via the miR-135b-APC axis. Oncogene\| PubMed ID: 37365220	2023
Application and Resistance Mechanisms of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma. Journal of hepatocellular carcinoma\| PubMed ID: 37457652	2023
Comparison of survival benefit and safety between surgery following conversion therapy versus surgery alone in patients with surgically resectable hepatocellular carcinoma at CNLC IIb/IIIa s... International journal of surgery (London, England)\| PubMed ID: 38353702	2024
SMYD4 monomethylates PRMT5 and forms a positive feedback loop to promote hepatocellular carcinoma progression. Cancer science\| PubMed ID: 38438251	2024
Integrated analysis reveals an aspartate metabolism-related gene signature for predicting the overall survival in patients with hepatocellular carcinoma. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico\| PubMed ID: 38472558	2024
Hepatitis B virus X protein represses expression of tumor suppressor PTPN18 in hepatocellular carcinoma. Molecular cancer research : MCR\| PubMed ID: 38787319	2024
A deep learning-based clinical-radiomics model predicting the treatment response of immune checkpoint inhibitors (ICIs)-based conversion therapy in potentially convertible hepatocelluar carc... International journal of surgery (London, England)\| PubMed ID: 40085751	2025
Multi-omics analysis identifies OSGEPL1 as an oncogene in hepatocellular carcinoma. Discover oncology\| PubMed ID: 40090949	2025
Integrated analysis reveals an immune evasion prognostic signature for predicting the overall survival in patients with hepatocellular carcinoma. Cancer cell international\| PubMed ID: 40102844	2025
March5-mediated Trim28 degradation preserves islet β-cell function in mice. Nature communications\| PubMed ID: 40750777	2025
mA-Modified circRAPGEF1 Interaction with IGF2BP3 Promotes Hepatocellular Carcinoma Progression via Reprogramming Aspartate Metabolism. Advanced science (Weinheim, Baden-Wurttemberg, Germany)\| PubMed ID: 40801445	2025